Insight Capital Research & Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-3,709	Closed	-$120K	–	159
2013 Q3	$120K	Buy	+3,709	New	+$120K	0.03%	161